Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JMP Securities Upgrades Deciphera Pharmaceuticals to Market Outperform, Announces $23 Price Target

JMP Securities Upgrades Deciphera Pharmaceuticals to Market Outperform, Announces $23 Price Target

JMP Securities analyst Reni Benjamin upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Market Perform to Market Outperform and announces $23 price target.

byBenzinga Newsdesk

August 5, 2022

1 minute read

JMP Securities analyst Reni Benjamin upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Market Perform to Market Outperform and announces $23 price target.

Chevron, Hess CEOs See ‘A Lot Of Upside’ For Shareholders Following $53B Deal

By Adam Eckert

October 23, 11:42 AM

Chevron Corp (NYSE: CVX) unveiled plans to buy Hess Corp (NYSE: HES) on Monday.

CVX

News

Why Shiba Inu (SHIB) Is Nosediving

By Henry Khederian

June 5, 2:03 PM

Shiba Inu (CRYPTO: SHIB) is experiencing a 6.46% decline, trading at $0.00000796 during Monday's session, in line with the overall weakness observed in the cryptocurrency market.

$SHIB

Why Is Trimble Stock Trading Lower Monday?

By Anusuya Lahiri

February 12, 9:22 AM

Trimble reported Q4 FY23 revenue growth of 9% to $932.40M, beating consensus. Adjusted EPS of $0.63 beat consensus. FY24 outlook: Revenue of $3.57B-$3.67B, adjusted EPS of $2.60-$2.80. TRMB shares down over 5% premarket.

TRMB